K Ca 3.1 channels mediate the increase of cell migration and proliferation by advanced glycation endproducts in cultured rat vascular smooth muscle cells

Laboratory Investigation

Volumn 93, Issue 2, 2013, Pages 159-167

  Zhao, Li Mei ^a   Su, Xing Li ^a,b   Wang, Yan ^a   Li, Gui Rong ^c   Deng, Xiu Ling ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AGEs; migration; proliferation; VSMCs

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; SMALL INTERFERING RNA; WORTMANNIN; 1,3 BUTADIENE DERIVATIVE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCTS BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; FLAVONOID; IMIDAZOLE DERIVATIVE; KCNN4 PROTEIN, RAT; MORPHOLINE DERIVATIVE; NITRILE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; CELL MOTION; CYTOLOGY; GENETICS; METABOLISM; PATCH CLAMP; PHYSIOLOGY; RNA INTERFERENCE;

ANALYSIS OF VARIANCE; ANDROSTADIENES; ANIMALS; BLOTTING, WESTERN; BUTADIENES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHROMONES; FLAVONOIDS; GLYCOSYLATION END PRODUCTS, ADVANCED; IMIDAZOLES; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MORPHOLINES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRILES; PATCH-CLAMP TECHNIQUES; PYRIDINES; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84873864396     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.163     Document Type: Article

References (33)

1. Singh R, Barden A, Mori T, et al. Advanced glycation end-products: a review. Diabetologia 2001;44:129-146.
2. Hudson BI, Schmidt AM. RAGE: a novel target for drug intervention in diabetic vascular disease. Pharm Res 2004;21:1079-1086.
3. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995;46:223-234.
4. Burke AP, Kolodgie FD, Zieske A, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004;24:266-1271.
5. Bucciarelli LG, Wendt T, Qu W, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E null mice. Circulation 2002;106:2827-2835.
6. Wendt T, Harja E, Bucciarelli L, et al. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Atherosclerosis 2006;185:70-77.
7. Soro-Paavonen A, Watson AM, Li J, et al. Receptor for advanced glycation endproducts (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008;57:2461-2469.
8. Sakaguchi T, Yan SF, Yan SD, et al. Central role of RAGE-dependent neointimal expansion. J Clin Invest 2003;111:959-972.
9. Yoon YW, Kang TS, Lee BK, et al. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med 2008; 40:398-406.
10. Reddy MA, Li SL, Sahar S, et al. Key role of Src kinase in S100b-induced activation of the receptor for advanced glycation endproducts in vascular smooth muscle cells. J Biol Chem 2006;281:13685-13693.
11. Neylon CB, Avdonin PV, Larsen MA, et al. Rat aortic smooth muscle cells expressing charybdotoxin-sensitive potassium channels exhibit enhanced proliferative responses. Clin Exp Pharmacol Physiol 1994;21:117-120.
12. Neylon CB, Lang RJ, Fu Y, et al. Molecular cloning and characterization of the intermediate-conductance Ca2+-activated K+ channel in vascular smooth muscle: relationship between KCa channel diversity and smooth muscle cell function. Circ Res 1999;85:e33-e43.
13. Si H, Grgic I, Heyken WT, et al. Mitogenic modulation of Ca2+-activated K+ channels in proliferating A7r5 vascular smooth muscle cells. Br J Pharmacol 2006;148:909-917.
14. Tharp DL, Wamhoff BR, Turk JR, et al. Upregulation of intermediateconductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 2006;291:H2493-H2503.
15. Kohler R, Wulff H, Eichler I, et al. Blockade of the intermediateconductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003;108:1119-1125.
16. Toyama K, Wulff H, Chandy G, et al. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 2008;118: 3025-3037.
17. Wang Y, Zhang HT, Su XL, et al. Experimental diabetes mellitus downregulates large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle and alters functional conductance. Curr Neurovas Res 2010;7:75-84.
18. Su XL, Wang Y, Zhang W, et al. Insulin-mediated upregulation of KCa3.1 channels promotes cell migration and proliferation in rat vascular smooth muscle. J Mol Cell Cardiol 2011;51:51-57.
19. Nyhlin N, Ando Y, Nagai R, et al. Advanced glycation end product in familial amyloidotic polyneuropathy. J Intern Med 2000;247:485-492.
20. Horiuchi S, Araki N, Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J Biol Chem 1991;266:7329-7332.
21. Tao R, Lau CP, Tse HF, et al. Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volumesensitive chloride channels in mouse mesenchymal stem cells. Am J Physiol Cell Physiol 2008;295:C1409-C1416.
22. Deng XL, Lau CP, Lai K, et al. Cell cycle-dependent expression of potassium channels and cell proliferation in rat mesenchymal stem cells from bone marrow. Cell Prolif 2007;40:656-670.
23. Chung CH, Lin KT, Chang CH, et al. The integrin a2b1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production. Br J Pharmacol 2009;156: 846-856.
24. Touré F, Fritz G, Li Q, et al. Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways. Circ Res 2012;110:1279-1293.
25. Stevenson AS, Cartin L, Wellman TL, et al. Membrane depolarization mediates phosphorylation and nuclear translocation of CREB in vascular smooth muscle cells. Exp Cell Res 2001;263:118-130.
26. Taubman MB, Berk BC, Izumo S, et al. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem 1989;64:526-530.
27. Pulver RA, Rose-Curtis P, Roe MW, et al. Store-operated Ca2+ entry activates the CREB transcription factor in vascular smooth muscle. Circ Res 2004;94:1351-1358.
28. Ghanshani S, Wulff H, Miller MJ, et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 2000;275:37137-37149.
29. Lee BH, Bae JS, Park RW, et al. big-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through avb5 integrin. Exp Mol Med 2006;38:153-161.
30. Srivastava S, Li Z, Ko K, et al. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Mol Cell 2006;24:665-675.
31. Di L, Srivastava S, Zhdanova O, et al. Nucleoside diphosphate kinase B knock-out mice have impaired activation of the K+ channel KCa3.1, resulting in defective T cell activation. J Biol Chem 2010;285: 38765-38767.
32. Srivastava S, Di L, Zhdanova O, et al. The class II phosphatidylinositol 3 kinase C2b is required for the activation of the K+ channel KCa3.1 and CD4 T-cells. Molecular. Biol Cell 2009;20:3783-3791.
33. Park S, Kim JA, Joo KY, et al. Globotriaosylceramide leads to KCa3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease. Cardiovasc Res 2011;89:290-299.